Currently viewing a development environment

Joshua Peters

Biological Engineering

Massachusetts Institute of Technology

I’m a PhD student in Biological Engineering at MIT. Around two billion people in the world are infected with a microscopic bug called Mycobacterium Tuberculosis. Despite this, only a fraction develop tuberculosis. And a fraction of those infected – almost 5,000 a day – die. I put on Stranger Things-esque protection equipment and probe these bacteria to ask, what allows them bacteria to win this tug-of-war? To understand this variation, I look at how both human and bacteria cells change on a genetic level in response to each other, as a member of the Blainey Lab, located in the Broad Institute, and Bryson Lab, located in the Ragon Institute and MIT.

Joshua has authored 15 articles

Researchers are abolishing an ancient epidemic — and trying to prevent the next one before it starts

Read now →

Using machine learning tools and viral sequences, researchers are trying to better understand disease transmission

Joshua Peters

A patient was cured of HIV. What should you expect in the future?

Read now →

Scientists are buoyed and see a path to future medicines

Joshua Peters

Comment 1 peer comment

Vaccines aren't yet using our immune system's full potential

Read now →

The most important invention in medicine could save even more lives

Joshua Peters

Why there probably won't be a 'magic bullet' for cancer

Read now →

Researchers increasingly view the disease as a sprawling, evolving metropolis of cells

Joshua Peters

Comment 2 peer comments

Why do the COVID-19 mRNA vaccines need to be kept so cold?

Read now →

The Pfizer and Moderna vaccine cold chains, explained

Joshua Peters

Humanity's viral stowaway is now a defense against our greatest diseases

Read now →

Engineered viruses may be the key to HIV and tuberculosis vaccines

Joshua Peters

Earth's weirdest creatures are genetic treasure chests

Read now →

From the axolotl's regenerating limbs to naked mole rat cancer resistance, new sequencing is uncovering new possibilities

Joshua Peters

Comment 1 peer comment

What are the advantages of an mRNA vaccine for COVID-19?

Read now →

They're easier to manufacture than traditional vaccines, but scientifically their history is checkered

Joshua Peters

Comment 1 peer comment

Knowing more about how sneeze droplets spray can help prevent disease

Read now →

Big and small droplets have different physics and even different pathogenic potential

Joshua Peters

Haven't heard of RNA therapy yet? You will

Read now →

After a decade of painstaking progress​, the underdog is on the brink of treating a broad range of diseases

Joshua Peters

How scientists are mapping the building blocks of life

Read now →

A microscopic moonshot hopes to revolutionize biology

Joshua Peters

How dogs are helping us understand human allergies

Read now →

If your dog has allergies, chances are you do too. Thanks, microbes

Joshua Peters

Billionaires are rushing into biotech. Inequality is following them into science

Read now →

'Free-market philanthropy' raises yet more questions about the future of American public research

Joshua Peters

Comment 2 peer comments

Did these scientists just create the first lab-grown human breast milk?

Read now →

Meet the two women recreating mother nature’s baby formula.

Joshua Peters

Exosuits can restore mobility in stroke patients and soldiers alike

Read now →

And they're customizable for different types of bodies, gaits, and speeds

Joshua Peters